| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.53B | — | +12.1% |
| Cost of Revenue | $665.2M | — | +4.0% |
| R&D Expense | $478.3M | — | +12.8% |
| SG&A Expense | $220.7M | — | -6.2% |
| Operating Income | -$74.4M | — | +61.6% |
| Pre-tax Income | -$85.8M | — | +34.6% |
| Income Tax | $3.2M | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.06B | +3.1% | +16.5% |
| Short-term Investments | $1.76B | -7.8% | -23.3% |
| Accounts Receivable | $1.19B | -13.5% | +2.6% |
| Current Assets | $4.28B | -6.7% | -6.5% |
| Total Assets | $7.50B | -2.3% | -1.2% |
| Current Liabilities |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $326.8M | — | +115.5% |
| Capital Expenditures | $40.8M | — | +9.6% |
| Investing Cash Flow | $57.3M | — | +1979.2% |
| Financing Cash Flow | -$352.1M | — | -22.0% |
| Free Cash Flow | $286.0M | — | +150.0% |
| -62.1% |
| Net Income | -$89.0M | — | +36.3% |
| EPS (Basic) | -$0.05 | — | +37.5% |
| EPS (Diluted) | -$0.05 | — | +37.5% |
| $1.21B |
| -5.7% |
| +14.1% |
| Long-term Debt | $3.54B | -0.0% | -2.1% |
| Total Liabilities | $5.42B | +0.4% | +2.6% |
| Stockholders' Equity | $2.08B | -8.6% | -9.8% |